A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
Public ClinicalTrials.gov record NCT00308191. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Week Double-Blind, Parallel-Group, Active-Controlled Trial to Compare the Efficacy and Safety of Concomitant Treatment of Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.
Study identification
- NCT ID
- NCT00308191
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- May 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Mar 7, 2008
2006
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Sepulveda | California | 91343 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Gainesville | Georgia | 30501 | — |
| Research Site | Auburn | Maine | 04210 | — |
| Research Site | Ann Arbor | Michigan | 48105 | — |
| Research Site | Livonia | Michigan | 48152 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Liverpool | New York | 13088 | — |
| Research Site | Rochester | New York | 14618 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Collegeville | Pennsylvania | 19426 | — |
| Research Site | El Paso | Texas | 79902 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00308191, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 7, 2008 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00308191 live on ClinicalTrials.gov.